Led by researchers from Heidelberg Faculty of Medicine at Heidelberg University and the University of California, San Francisco (U.S.), an international team has evaluated a novel approach for the ...

EarlyDiagnostics, Inc. ("EarlyDx"), a clinical-stage liquid biopsy company developing precision diagnostics, today announced that its proprietary MethylScantm platform has been validated in a ...

Impact of Race, Socioeconomic Status, and Clinicopathologic Features on Clinical Outcomes in Triple-Negative Breast Cancer in the ECOG-ACRIN EA1131 Trial A substantial proportion of cancers are ...

Why structure matters: Frameworks like ABCDE standardize patient assessment, helping responders act quickly and consistently under pressure. From scene to bedside ...

A new research paper was published in Volume 18 of Aging-US on April 24, 2026, titled “The BHARAT study: a multi-modal, multi ...

Researchers compared outcomes of individuals who had a stem cell transplantation who were randomly assigned to receive obinutuzumab or placebo after their transplantation.

Short-course radiotherapy-based total neoadjuvant therapy combined with tislelizumab in the treatment of locally advanced rectal cancer (Neo-STAR): Early outcomes of a prospective, randomized phase II ...

Earnings call Intuitive Surgical delivered a robust Q1 2026, with revenue up 23% YoY to $2.77B and non-GAAP EPS rising to $2.50 (up from $1.81). Procedure growth was strong at 17%, led by da Vinci 5 ...

Glioblastoma remains one of the most lethal primary brain tumors, with limited durable benefit from current standard-of-care approaches. In parallel, ...